ModelEdge

PharmaCyte Biotech Inc.
PMCB
Filing TypeS-3
Filing Date9/16/2025
Updated9/16/25, 4:56 PM

Filing

S-3
Earnings Release

Exhibits

S-3Registration Statement for Securities Offered under a Shelf Registration
EX-3.1CERTIFICATE OF DESIGNATIONS FOR THE SERIES C CONVERTIBLE PREFERRED STOCK.
EX-4.2FORM OF PLACEMENT AGENT WARRANT.
EX-5.1OPINION OF MINTZ, LEVIN, COHN, FERRIS, GLOVSKY, AND POPEO P.C.
EX-23.1CONSENT OF CBIZ CPAS P.C.
EX-23.2CONSENT OF MARCUM LLP.
EX-FILING FEESFILING FEE IXBRL
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic